Видео ютуба по тегу Esr1

A Dive into ESR1 Protein: What it is and Why It Matters
A Dive into ESR1 Protein: What it is and Why It Matters
Breast Cancer Breakthroughs: The Importance of ESR1 mutations in metastatic breast cancer
Breast Cancer Breakthroughs: The Importance of ESR1 mutations in metastatic breast cancer
ESR1 Mutated Metastatic Breast Cancer Market Size was ~USD 800 Million in 2022
ESR1 Mutated Metastatic Breast Cancer Market Size was ~USD 800 Million in 2022
Understanding Progression: How to Identify and Treat ESR1 Mutations in HR+ MBC
Understanding Progression: How to Identify and Treat ESR1 Mutations in HR+ MBC
ESR1 testing guides treatment in metastatic breast cancer
ESR1 testing guides treatment in metastatic breast cancer
The Digitalgaesation Project: ESR1 presentation
The Digitalgaesation Project: ESR1 presentation
Transcriptional reprogramming , ESR1 Mutations , novel targets and treatment | RGCIRC
Transcriptional reprogramming , ESR1 Mutations , novel targets and treatment | RGCIRC
ELAINE 1: ESR1 mutations in ctDNA from ER+/HER2- mBC treated with lasofoxifene or fulvestrant
ELAINE 1: ESR1 mutations in ctDNA from ER+/HER2- mBC treated with lasofoxifene or fulvestrant
Dr. Fuqua on ESR1 Mutations in Primary Breast Cancer
Dr. Fuqua on ESR1 Mutations in Primary Breast Cancer
SABCS 2021:
SABCS 2021: "Transcriptional reprogramming, ESR1 mutations, and novel targets and treatment"
PEARRL ESR1 Niklas Koehl
PEARRL ESR1 Niklas Koehl
Identifying ESR1 Mutations for ORSERDU Eligibility
Identifying ESR1 Mutations for ORSERDU Eligibility
🚨The Threat Lurking Beneath the Surface: #ESR1 Mutations in ER+/HER2- #BreastCancer🚨
🚨The Threat Lurking Beneath the Surface: #ESR1 Mutations in ER+/HER2- #BreastCancer🚨
ESR1 Mutation: The Need for & Role of Testing in ER+/ HER2- Advanced or Metastatic Breast Cancer
ESR1 Mutation: The Need for & Role of Testing in ER+/ HER2- Advanced or Metastatic Breast Cancer
ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?
ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?
ESR1 Mutations in Focus: Are PROTACs the Next Breakthrough?
ESR1 Mutations in Focus: Are PROTACs the Next Breakthrough?
ESR1 mutation in untreated EC: prevalence, characteristics and prognosis from the UTOLA trial
ESR1 mutation in untreated EC: prevalence, characteristics and prognosis from the UTOLA trial
Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcomes in HR+ Advanced Breast Cancer
Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcomes in HR+ Advanced Breast Cancer
Unlocking ESR1 Mutations in Breast Cancer
Unlocking ESR1 Mutations in Breast Cancer
ESR1 Mutations: Understanding your Test Results
ESR1 Mutations: Understanding your Test Results
aprilia esr1
aprilia esr1
SABCS 2023: State of the Art - Targeting Mutant ER
SABCS 2023: State of the Art - Targeting Mutant ER
Dr. Tolaney on Presence of PIK3CA and ESR1 Mutations in MONARCH 2 Trial in Breast Cancer
Dr. Tolaney on Presence of PIK3CA and ESR1 Mutations in MONARCH 2 Trial in Breast Cancer
EasyPGX® Ready ESR1
EasyPGX® Ready ESR1
Treatment Options for Patients with ESR1 Mutated Breast Cancer after CDK4/6i Progression
Treatment Options for Patients with ESR1 Mutated Breast Cancer after CDK4/6i Progression